These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16534090)

  • 1. Managing low-grade cervical lesions.
    Burn R
    CMAJ; 2006 Mar; 174(6):813; author reply 813-4. PubMed ID: 16534090
    [No Abstract]   [Full Text] [Related]  

  • 2. Managing low-grade cervical lesions.
    Howlett R; Bryson P; Mai V; McLachlin M
    CMAJ; 2006 Mar; 174(6):813; author reply 813-4. PubMed ID: 16534091
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of low-grade cervical lesions in young women.
    Lau S; Franco EL
    CMAJ; 2005 Sep; 173(7):771-4. PubMed ID: 16186584
    [No Abstract]   [Full Text] [Related]  

  • 4. Cervical cancer screening clinical practice guidelines in oncology.
    Partridge EE; Abu-Rustum NR; Campos S; Edelson M; Fahey PJ; Fiorica J; Greer BE; Lieberman RW; Likes W; Molpus KL; Nava ME; Reynolds RK; Singh DK; Smith-McCune K; Soper J; Teng N; Trimble CL; Wilczynski S;
    J Natl Compr Canc Netw; 2004 Nov; 2(6):570-87. PubMed ID: 19780301
    [No Abstract]   [Full Text] [Related]  

  • 5. Managing Minimally Abnormal Cervical Cancer Screening Test Results.
    Sawaya GF; Lamar R; Perkins RB
    JAMA; 2020 Oct; 324(15):1557-1558. PubMed ID: 32975557
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancer screening in the young female.
    Kaufman RH
    Arch Pathol Lab Med; 2011 Mar; 135(3):296-7. PubMed ID: 21366450
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence-based, alternative cervical cancer screening approaches in low-resource settings.
    Sherris J; Wittet S; Kleine A; Sellors J; Luciani S; Sankaranarayanan R; Barone MA
    Int Perspect Sex Reprod Health; 2009 Sep; 35(3):147-54. PubMed ID: 19805020
    [No Abstract]   [Full Text] [Related]  

  • 8. [Preinvasive lesions in gynaecology - uterine cervix].
    Mouková L; Feranec R; Chovanec J
    Klin Onkol; 2013; 26 Suppl():S49-51. PubMed ID: 24325165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical cancer guidelines. Clinical practice guidelines in oncology.
    Teng N; Abu-Rustum NR; Bahador A; Bookman MA; Bristow RE; Campos S; Cho KR; Copeland L; Eifel P; Fiorica J; Greer BE; Kapp DS; Kavanagh J; Koh WJ; Kuettel M; Lurain JR; Molpus KL; Nag S; Partridge EE; Powell CB; Reynolds RK; Small W; Soper J; Tillmanns TD;
    J Natl Compr Canc Netw; 2004 Nov; 2(6):612-30. PubMed ID: 19780304
    [No Abstract]   [Full Text] [Related]  

  • 10. Practice Bulletin No. 140: management of abnormal cervical cancer screening test results and cervical cancer precursors.
    American College of Obstetricians and Gynecologists
    Obstet Gynecol; 2013 Dec; 122(6):1338-67. PubMed ID: 24264713
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of the patient with an abnormal Papanicolaou smear.
    Chirenje ZM
    Cent Afr J Med; 1994 May; 40(5):131-4. PubMed ID: 7954725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and management of cervical intraepithelial neoplasia.
    Flowers LC; McCall MA
    Obstet Gynecol Clin North Am; 2001 Dec; 28(4):667-84, viii. PubMed ID: 11766144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Status quo and prevention of overtreatment in cervical diseases.
    Tianmin X; Weiqin C; Manhua C; Yang L; Lihui S; Tianshu W; Xiaocui L
    Eur J Gynaecol Oncol; 2012; 33(3):300-3. PubMed ID: 22873104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical dysplasia in women with HIV.
    Goodman L; Croke V; Rodman A; Alexander MK
    Nurse Pract; 1999 Aug; 24(8):79-80, 82, 84-5. PubMed ID: 10479112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the cost-effective evaluation and management of atypical squamous cells of undetermined significance and low grade squamous intraepithelial lesions.
    Horowitz IR
    Cancer; 1998 Feb; 84(1):1-4. PubMed ID: 9500645
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study.
    Kocken M; Helmerhorst TJ; Berkhof J; Louwers JA; Nobbenhuis MA; Bais AG; Hogewoning CJ; Zaal A; Verheijen RH; Snijders PJ; Meijer CJ
    Lancet Oncol; 2011 May; 12(5):441-50. PubMed ID: 21530398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Avoiding Unnecessary Treatment of Cervical Intraepithelial Neoplasia Grade 2.
    Del Mistro A
    Clin Infect Dis; 2020 Jun; 70(12):2591-2592. PubMed ID: 31344228
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of cervical precancers: a global perspective.
    Echelman D; Feldman S
    Hematol Oncol Clin North Am; 2012 Feb; 26(1):31-44. PubMed ID: 22244660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of cervical dysplasia with colposcopy in Finland].
    Zilliacus R; Nieminen P
    Duodecim; 2003; 119(1):50-5. PubMed ID: 12607472
    [No Abstract]   [Full Text] [Related]  

  • 20. Incidence, pathophysiology and treatment of cervical cancer.
    Dunleavey R
    Nurs Times; 2004 Nov 2-8; 100(44):38-41. PubMed ID: 15552491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.